| Application no. and date | 05783113.3 (espacenet) (Federated) (European Patent Register), 20050912 | | Patent/reg. no. and date | DK/EP 1794163, 20091223 | | Publication date | 20070613 | | Priority no. and date | US 612457 P, 20040922 | | EP pub. no. and date |
EP 1794163 20070613 | | Effective date | | | Applicant/owner | Cancer Research Technology Limited, Sardinia House, Sardinia Street
London WC2A 3NL, GB,
Pfizer, Inc., 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | P81000645DK00E | | Inventor | MA, Chunrong
Agouron Pharmaceuticals, Inc., A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121, US,
NAYYAR, Naresh
Agouron Pharmaceuticals, Inc., A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121, US,
STANKOVIC, N. S.
Agouron Pharmaceuticals, Inc., A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 487/06 (2006.01) | | Title | Fremgangsmåde til fremstilling af poly(ADP-ribose)polymeraseinhibitorer | | Int. application no. | IB2005002881 | | Int. publication no. | WO2006033003 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
